Trials / Completed
CompletedNCT07514559
Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 393 (actual)
- Sponsor
- Hospital Hietzing · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study compares the perceived treatment burden in patients undergoing intravitreal anti-VEGF treatment for either wet age related macular degeneration, macular edema after retinal vein occlusions or diabetic macular edema. This study is the first to the investigator's knowledge to compare treatment burden between all three patient groups, which also differ in age and socioeconomic circumstances. The results are of interest to all ophthalmologists who prescribe anti-VEGF treatments, as they show factors which can influence patient adherence und thus the efficacy of said therapies.
Conditions
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2026-04-07
- Last updated
- 2026-04-07
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT07514559. Inclusion in this directory is not an endorsement.